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Background: Little is known about the clinical management of patients in primary care following self-
harm.
Methods: A descriptive cohort study using data from 684 UK general practices that contributed to the
Clinical Practice Research Datalink (CPRD) during 2001–2013. We identiﬁed 49,970 patients with a self-
harm episode, 41,500 of whom had one complete year of follow-up.
Results: Among those with complete follow-up, 26,065 (62.8%, 62.3–63.3) were prescribed psychotropic
medication and 6318 (15.2%, 14.9-15.6) were referred to mental health services; 4105 (9.9%, CI 9.6–10.2)
were medicated without an antecedent psychiatric diagnosis or referral, and 4,506 (10.9%, CI 10.6–11.2)
had a diagnosis but were not subsequently medicated or referred. Patients registered at practices in the
most deprived localities were 27.1% (CI 21.5–32.2) less likely to be referred than those in the least de-
prived. Despite a speciﬁcally ﬂagged NICE 'Do not do’ recommendation in 2011 against prescribing tri-
cyclic antidepressants following self-harm because of their potentially lethal toxicity in overdose, 8.8% (CI
7.8-9.8) of individuals were issued a prescription in the subsequent year. The percentage prescribed
Citalopram, an SSRI antidepressant with higher toxicity in overdose, fell sharply during 2012/2013 in the
aftermath of a Medicines and Healthcare products Regulatory Agency (MHRA) safety alert issued in 2011.
Conclusions: A relatively small percentage of these vulnerable patients are referred to mental health
services, and reduced likelihood of referral in more deprived localities reﬂects a marked health in-
equality. National clinical guidelines have not yet been effective in reducing rates of tricyclic anti-
depressant prescribing for this high-risk group.
& 2016 Elsevier B.V. All rights reserved.1. Introduction
Self-harm is one of the strongest risk factors for death by sui-
cide (Cooper et al., 2007; Bergen et al., 2012) and generall Practice Research Datalink;
Practitioner; IMD, Index of
t Area; MHRA, Medicines and
al Health Service; NICE, Na-
RI, Selective Serotonin Re-
Life Lost
M.J. Carr).practitioners (GPs) play an important role in managing risk among
patients who have recently harmed themselves. However, re-
search evidence for the clinical management of self-harm speci-
ﬁcally in primary care settings is lacking because most published
studies have been conducted using hospital emergency depart-
ment and admissions data. Nonetheless, the important role played
by primary care in the assessment of people who self-harm was
emphasised in 2004 by National Institute for Health and Care
Excellence (NICE) clinical guideline 16: Self-harm: the short-term
physical and psychological management and secondary prevention of
self-harm in primary and secondary care (NICE, 2004). Despite this
strong emphasis, just 14 of its 152 recommendations provided
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3 of the 57 recommendations made in 2011 by NICE clinical
guideline 133: Self-harm: longer-term management (NICE, 2011).
This lack of recommendations speciﬁc to primary care is linked to
the absence of research evidence for this topic.
We examined a cohort extracted from the Clinical Practice
Research Datalink (CPRD) (DoH, 2011; Herrett et al., 2015). This
data source enabled us to examine primary care clinical manage-
ment following an episode of self-harm using data from general
practices located across the UK. The purpose was not to compre-
hensively ascertain all incident cases of self-harm in the popula-
tion, including all cases treated in secondary care settings. Rather
it was to investigate individuals whose recent self-harm episodes
have been brought to the attention of their GPs. We initially pro-
ﬁled those patients who had an antecedent psychiatric diagnosis
or a new one following their index self-harm episode. However,
our primary outcomes were the percentage of cohort members
receiving a referral to mental health services or prescribed psy-
chotropic medication in the subsequent year. We paid particular
attention to medication that can be fatally toxic in overdose, such
as tricyclic antidepressants. Finally, we aimed to assess variability
in clinical management by age and gender and by practice-level
deprivation.2. Methods
2.1. Description of the data source and study cohort
The December 2013 CPRD extract that we examined included
684 general practices and more than 13 million patients, with age
and gender distributions comparable to those for the whole UK
population (Herrett et al., 2015; García Rodríguez and Pérez Gut-
thann, 1998). Validation studies have reported consistently high
CPRD quality data (Herrett et al., 2015; Khan et al., 2010). The Read
code system (Chisholm, 1990), the standard for UK general prac-
tice, is routinely applied in the dataset. It provides a structured
hierarchy of terms relating to demography and lifestyle, symp-
toms, diagnoses, therapies, referrals, and laboratory test results
(HSCIC, 2015).
We delineated the study cohort using a broad deﬁnition that
incorporated all forms of self-harm from the mildest non-suicidal
episodes through to near-fatal attempted suicide, as described
previously (Carr et al., 2016). Our deﬁnition excluded alcohol-re-
lated poisonings and suicidal ideation not involving actual self-
harm acts. We initially identiﬁed potentially relevant Read codes
using the search terms 'deliberate’, 'intent’ or 'self’ (to identify
episodes of self-harm/harming, self-injury/injurious behaviour,
self-inﬂicted harm/injury, harm/injury to self, self-poisoning, de-
liberate overdose, intentional overdose, etc.) and 'suicide attempt’,
'attempted suicide’ or 'parasuicide’ (to identify suicide attempts).
The list of codes was then reviewed rigorously by two clinicians in
the study team (NK and JC) and cross-referenced with a compar-
able list obtained from a recent CPRD-based validation study on
suicide and self-harm (Thomas et al., 2013). Our ﬁnal list can be
downloaded from the 'ClinicalCodes.org’ repository (Springate
et al., 2014).
An index self-harm episode was deﬁned as the ﬁrst occasion on
which a Read code from our list was entered in a patient's clinical
record. Limiting our extraction to patients deemed as being ‘up to
standard’ for research purposes by the CPRD, our cohort consisted
of individuals with a recorded index episode from 1st January
2001 to 31st December 2012. Patients were eligible for inclusion in
a given year if they were aged 15–64 years and registered with a
CPRD-contributing practice at the start of the year. The rationale
for imposing these age restrictions was that the determinants andimplications of self-harm in children and older adults are quite
distinct from those of the rest of the population, and therefore
warrant separate investigation and consideration. Among older
persons who harm themselves, speciﬁc mechanisms such as be-
reavement, loneliness and social isolation (De Leo et al., 2001;
Lebret et al., 2006) and physical illness, multi-morbidity and im-
pairment (Lebret et al., 2006) play a predominant role; children
aged below 15 years who harm themselves tend to have an unu-
sually low suicidal intent and therefore a relatively low long-term
risk of dying by suicide (Hawton and Harriss, 2008). To increase
the likelihood that these were incident cases on entry into the
study cohort, we stipulated that patients had to have been regis-
tered with a contributing CPRD practice on a continuous basis for
at least a year prior to the index self-harm episode.
2.2. Classiﬁcation and measurement
2.2.1. Referrals and prescriptions
These were our two primary clinical management measures.
We examined referrals to mental health services and psychotropic
medication prescribing that was recorded subsequent to the index
self-harm episode and during the 1 year follow-up period. We
identiﬁed referrals to relevant mental health services using two
CPRD ﬁelds. Firstly, a Family Health Services Authority (FHSA)
variable indicated the department to which the patient was re-
ferred. General practitioners are required to enter this information
upon referral, and for our purposes ‘Psychiatry’ was the only re-
levant department. Secondly, we also utilised the National Health
Service (NHS) specialty ﬁeld. This contains more granular in-
formation, but completion by general practice staff is not com-
pulsory when coding referrals. The NHS specialty classiﬁcation
included eight mental health codes: mental illness; child and
adolescent psychiatry; forensic psychiatry; psychotherapy; old age
psychiatry; clinical psychology; adult psychiatry; and community
psychiatric nurse. We combined information from both the FHSA
and NHS ﬁelds to construct a binary specialist mental health ser-
vices referral indicator. The dataset also contains complete records
of all prescribed medication. We extracted all prescriptions in the
following psychotropic medication classes: typical, atypical and
depot antipsychotics; lithium and other mood stabilisers; selective
serotonin reuptake inhibitor (SSRI), tricyclic and other anti-
depressants; benzodiazepines; opioid analgesics; other anxiolytics
and hypnotics. Our list of Multilex product (FirstDataBank, 2014)
codes for denoting psychotropic medications can be downloaded
from ‘ClinicalCodes.org’ (Springate et al., 2014).
2.2.2. Diagnoses
Psychiatric diagnoses were measured according to any prior
history or a new diagnosis made after the index self-harm episode.
They were classiﬁed as: schizophrenia-spectrum; bipolar disorder;
depression; anxiety disorders; personality disorders; and eating
disorders. Read code lists were compiled for each diagnostic ca-
tegory and were reviewed by two clinically qualiﬁed study team
members (NK and JC). The ﬁnal lists can be accessed at ‘Clin
icalCodes.org’ (Springate et al., 2014); a rationale for these coding
decisions is given in Supplemental ﬁle 1.
2.2.3. Clinical consultation
The CPRD ‘consultation type’ ﬁeld contains 59 categories, in-
cluding numerous options that denote telephone consultations or
administrative processes. A previous CPRD-based case-control
study of death by suicide found that just eight of these categories
were used in 96% of patient record entries (Appleby et al., 2014).
As in that study, to provide a stringent measure of face-to-face
contact with a GP or practice nurse, we applied categories 1
(‘clinic’) and 9 (‘surgery consultation’) only to derive our clinical
Table 1
Cohort members’ demographic information.
All Male Female
Total cohort size (N) 47,970 20,325 27,645
Gender (%) – 42.4 57.6
Median age (IQR) 30 (20,42) 32 (22,43) 28 (19,41)
Patients with less than 1 year of
follow-up:
Number of patients (% of Total N) 6470 (13.5) 3142 (15.5) 3328 (12.0)
Gender (row %) – 48.6 51.4
Median age (IQR) 31 (21,42) 34 (24,45) 27 (19,39)
Lost to follow-up (% of Total N):
Died from any cause 2.1 3.8 0.9
Transferred out of practice 9.3 9.7 9.0
Practice no longer contributing
to CPRD
2.1 1.9 2.2
Patients with complete 1 year of
follow-up:
Number of patients (% of Total N) 41,500
(86.5)
17,183
(84.5)
24,317 (88.0)
Gender (row %) – 41.4 58.6
Median age (IQR) 30 (20,42) 31 (22,43) 29 (19,42)
Table 2
Mental health services referrals and psychotropic medication prescriptions during
1 year follow-up.
Total Referred Prescribed
N n % n %
Overall 41,500 6,318 15.2 26,065 62.8
Male 17,183 2,467 14.4 10,405 60.6
Age
15–24 5,925 813 13.7 2,397 40.5
25–34 3,898 586 15.0 2,485 63.8
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2.2.4. Deprivation
We applied an ecological measure at practice postcode level:
the 2010 Indices of Multiple Deprivation (IMD) for England, Wales,
Scotland and Northern Ireland.(Department for Communities and
Local Government, 2012; The Scottish Government, 2012; The
Welsh Government, 2010; Northern Ireland Statistics and Research
Agency, 2010) The IMD reﬂects social and material deprivation
among areas generally housing 1000–3000 residents, enabling
rank ordering of area-level scores. We examined four separate
quintile variables, which were generated from the continuous IMD
scores, according to the distributions of the four UK nations.
2.3. Statistical analyses
All analyses were performed using Stata version 13 (StataCorp,
2013). We examined clinical events occurring within one year after
the index self-harm episode. We stratiﬁed our analyses by gender,
age in 10-year intervals and deprivation quintile. Due to the large
cohort size and abundant statistical power, we found numerous
instances of statistically signiﬁcant heterogeneity by gender, age
and deprivation albeit with only small absolute differences ob-
served. Thus, we placed greater emphasis on the strength of as-
sociation rather than p-values. We calculated 95% conﬁdence in-
tervals for binomial proportions using Wilson's method (Wilson,
1927) rather than applying a normal approximation, and we used
Koopman's method to calculate the conﬁdence interval for a ratio
of two proportions (Koopman, 1984). The ﬁnal cohort observation
date was 31st December 2013. Therefore, patients with index
episodes after 31st December 2012 were excluded because a full
year of follow-up data was unavailable. We calculated the time
elapsed from index self-harm episode to ﬁrst recorded subsequent
referral, only for those referrals occurring within a year of the
index episode.35–44 3,702 557 15.1 2,698 72.9
45–54 2,374 337 14.2 1,818 76.6
55–64 1,284 174 13.6 1,007 78.4
IMD quintile
1 2,182 383 17.6 1,318 60.4
2 2,743 439 16.0 1,647 60.0
3 3,185 488 15.3 1,969 61.8
4 4,146 548 13.2 2,530 61.0
5 4,927 609 12.4 2,941 59.7
Female 24,317 3,851 15.8 15,660 64.4
Age
15–24 10,368 1,557 15.0 4,364 42.1
25–34 4,348 780 17.9 3,293 75.7
35–44 4,957 841 17.0 4,069 82.1
45–54 3,255 497 15.3 2,754 84.6
55–64 1,389 176 12.7 1,180 85.0
IMD quintile
1 3,444 632 18.4 2,207 64.1
2 4,255 776 18.2 2,771 65.1
3 4,610 752 16.3 2,939 63.8
4 5,718 824 14.4 3,698 64.7
5 6,290 867 13.8 4,045 64.3
Patients that did not complete one year of follow-up were excluded
IMD quintile 1 denotes least deprived and quintile 5 most deprived3. Results
3.1. Description of the study cohort
The full cohort consisted of 47,970 patients with an index self-
harm episode during 2001–2012. The median follow-up time was
3.7 years (interquartile range: 1.7–6.8 years) and 41,500 (86.5%)
patients had at least one full year of follow-up. Thus, 6470 patients
(13.5%) did not complete the full follow-up year, with the per-
centage being higher in male patients than in females (15.5%
versus 12.0%: Table 1). Almost a tenth (4,475; 9.3%, CI 9.1–9.6) of
the total cohort with an index self-harm episode transferred to
another practice during the follow-up year, and 1,052 (2.2%, 2.1–
2.3) died; 4.0% (CI 3.7–4.2) of the male patients and 0.9% (CI 0.8–
1.0) of the females died. Most of the 41,500 patients in the cohort
with complete follow-up were female (24,317; 58.6%). They ten-
ded to be somewhat younger than their male counterparts, with a
median age of 29 versus 31 years for males.
3.2. Psychiatric diagnoses, and subsequent referral and medication
prescribing
For the remainder of Section 3, we focus on the cohort mem-
bers with a full year of follow up. Almost two thirds (26,389;
63.6%, CI 63.1–64.1) had an antecedent or new psychiatric diag-
nosis. Table 2 presents the percentages of patients who received
psychotropic medication prescriptions or were referred to mental
health services referrals in the year after their index episode: 6318
(15.2%, CI 14.9–15.6) were referred and 26,065 (62.8%, 62.3–63.3)were prescribed psychotropic medication. No strong gender dif-
ferences in these percentages were apparent, but older patients of
both genders were far more likely to receive a prescription after
the index episode. Of the 6318 referrals recorded, the majority
(3368; 53.3%) occurred within the ﬁrst month of follow-up. Pa-
tients registered with practices in the most deprived localities
were 27.1% (CI 21.5–32.2) less likely to be referred than those in
the least deprived. Fig. 1 highlights the downward gradient in rates
of referral to mental health services in relation to rising levels of
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Fig. 1. Percentage of patients referred to mental health services during the 1 year
follow-up compared with number who self-harmed by deprivation quintile.
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crementally from the least to the most deprived IMD quintile.
The Venn diagram shown in Fig. 2 depicts the percentages of
cohort members who had antecedent or new psychiatric diag-
noses, and who were referred or medicated during the follow-up
year. 4105 (9.9%, CI 9.6–10.2) were prescribed psychotropic med-
ication without a diagnosis or subsequent referral to mental health
services, and 4506 (10.9%, CI 10.6–11.2) had a diagnosis but were
not subsequently medicated or referred. Almost a quarter of co-
hort members (9648; 23.2%, CI 22.8–23.7) had no psychiatric di-
agnosis and were not subsequently referred or medicated.
In Supplemental ﬁle 2, we provide detailed information on
diagnostic categories recorded at any time (historically or in the
follow-up year combined), and new diagnoses made speciﬁcally
during the 1 year follow-up. Consistent with prior expectation, the
numerically dominant diagnostic groups in both genders were
depression followed by anxiety disorders. Gender differences were
modest for all diagnostic categories examined. In Table 3 we pre-
sent the percentages of patients receiving prescriptions forFig. 2. Venn diagram showing percentage values for patients with antecedent or
new psychiatric diagnoses and with mental health service referrals or psychotropic
drug prescriptions during the 1 year follow-up.individual psychotropic medication classes during the follow-up
year. Predictably, SSRI antidepressants were the most frequently
prescribed drug type, and other antidepressants, benzodiazepines,
opioid analgesics and other anxiolytics/hypnotics were also com-
monly prescribed.
Although they are known to be potentially fatally toxic in
overdose, almost a tenth (3,985; 9.6%, CI 9.3–9.9) of cohort
members were prescribed tricyclic antidepressant medication
during the year after their index self-harm episode. Because of the
clinical importance of this ﬁnding, we additionally examined
temporal trends in SSRI versus tricyclic antidepressant prescribing.
The trends plotted in Fig. 3a show increases in the percentages of
cohort members prescribed SSRIs and other non-tricyclic anti-
depressant types during the follow-up year across the whole study
period, but there was no compensatory fall over time in the per-
centage of patients prescribed a tricyclic. This percentage re-
mained high throughout the 12 years of observation; it was 8.8%
(CI 7.8–9.8) among patients whose index self-harm episode oc-
curred during 2012 and who were followed up into 2013.
Fig. 3b plots temporal trends in the percentages of patients
prescribed speciﬁc types of SSRIs. There was no discernible trend
over the observation period in the percentages prescribed Fluox-
etine or Fluvoxamine maleate. The percentage prescribed Parox-
etine fell over time, especially in the earlier years of observation,
and that for Sertraline increased sharply during the later years.
Finally, the percentages prescribed Citalopram, and its S-en-
antiomer Escitalopram, fell over time; for Citalopram the percen-
tage rose steadily across the study period until falling sharply in
2012/2013 with cohort members whose index self-harm episodes
occurred during 2012.
We examined the characteristics of the patients in the study
cohort who were prescribed tricyclic antidepressant medication.
Of the 3985 patients prescribed a tricyclic antidepressant within a
year of their index self-harm episode, 2466 (61.9%) were female
and 64.8% were aged 35 years or older. Most patients (70.4%) had a
diagnosis of depression prior to the date of their ﬁrst tricyclic
prescription during follow-up, and 10.4% had a diagnosis of de-
pression recorded on the same day as this prescription was issued.
In Table A3 (in the online Supplemental material), we present
the frequencies and percentage values for the following three
measures:
1. Ever prescribed an SSRI and/or other ADD at any time before ﬁrst
tricyclic prescription during follow-up.
2. Prescribed an SSRI and/or other ADD within a year prior to ﬁrst
tricyclic prescription during follow-up.
3. Prescribed an SSRI and/or other ADD between index self-harm
episode and ﬁrst tricyclic prescription during follow-up.
The purpose of these analyses was to assess the degree to
which tricyclic antidepressant medication was used as ﬁrst-line
treatment in the study cohort, as opposed to being a therapeutic
approach that was taken only after SSRIs and/or other anti-
depressants had been prescribed. Among those prescribed tri-
cyclics, 22.3% (95% CI 21.0–23.6%) had never been prescribed an
SSRI and/or any other type of antidepressant, 39.2% (CI 37.7–40.7%)
had not been prescribed these alternative antidepressant therapies
within a year of ﬁrst being prescribed tricyclics, and 64.5% (63.0–
65.9%) had not been prescribed them between index self-harm
episode and subsequent ﬁrst tricyclic prescription. Among the
subset of cohort members prescribed tricyclics, prior prescribing of
an SSRI and/or another type of antidepressant medication was
more common in female than in male patients.
12
3
Table 3
Psychotropic prescribing by type during 1 year follow-up.
All (N¼41,500) Male (N¼17,183) Female (N¼24,317)
Psychotropic medication n % n % n %
Typical antipsychotics 2,292 5.5 773 4.5 1,519 6.3
Atypical antipsychotics 3,319 8.0 1,556 9.1 1,763 7.3
Depot antipsychotics 72 0.2 31 0.2 41 0.2
Lithium and other mood stabilisers 1,901 4.6 787 4.6 1,114 4.6
SSRI antidepressants 17,030 41.0 6,280 36.6 10,750 44.2
Tricyclic antidepressants 3,985 9.6 1,519 8.8 2,466 10.1
Other antidepressants 6,580 15.9 2,586 15.1 3,994 16.4
Benzodiazepines 7,637 18.4 3,139 18.3 4,498 18.5
Opioid analgesics 5,605 13.5 2,252 13.1 3,353 13.8
Other anxiolytics and hypnotics 5,592 13.5 2,201 12.8 3,391 13.9
Any psychotropic medication 26,065 62.8 10,405 60.6 15,660 64.4
All analyses restricted to patients with at least one year of follow-up.
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Fig. 3. a. Temporal trends in the percentage of cohort members prescribed tricyclics, SSRIs and other antidepressants during the 1 year follow-up. 3b. Temporal trends in the
percentage of cohort members prescribed particular types of SSRI antidepressants during the 1 year follow-up. Footnote: The x-axis values show the calendar year period
when index self-harm episodes occurred. Each cohort member was followed up for 1 complete year. Thus, an individual born on 31st December 2012 was followed up to 31st
December 2013, which was the ﬁnal date of observation in our study.
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The median consultation frequency during the year after the
index episode was 7 visits (interquartile range: 3–12). Male pa-
tients consulted less frequently, with a median of 5 visits (inter-
quartile range: 2–10), compared with a median among females of
8 visits (interquartile range: 4–13). Overall, 2961 (7.1%, CI 6.9–7.4)
cohort members did not consult once during the follow-up year,
with males being more likely to be non-attenders (1954; 11.4%, CI
10.9–11.9) than females (1007; 4.1%, CI 3.9–4.4).4
5
4. Discussion
4.1. Key ﬁndings
For the ﬁrst time, this study provides population-based evi-
dence illustrating clinical management patterns among UK pa-
tients in primary care who have recently harmed themselves. Our
ﬁndings indicate that general practices have major challenges to
address if they are to provide optimal care for patients following
self-harm. The most important ﬁndings were as follows:
) Overall, the percentage of patients subsequently referred to
mental health services was relatively low, and patients regis-
tered at practices in more deprived areas were less likely to be
referred than those in less deprived areas.) Almost a tenth of cohort members were prescribed psycho-
tropic medication without an antecedent or new psychiatric
diagnosis or subsequent referral to mental health services, and
nearly eleven percent had a diagnosis but were not subse-
quently medicated or referred.
) A considerable proportion of patients, almost a tenth across the
whole 12-year observation period and still nearly nine percent
during 2012–2013, received potentially fatally toxic tricyclic
antidepressant medication soon after harming themselves, and
twenty-two percent of these patients had never been prescribed
a different type of antidepressant drug previously.
) The percentage of cohort members prescribed Citalopram fell
sharply during 2012/2013.
) Nearly a tenth of cohort members moved practices during the
follow-up year and, among those patients with a complete year
of follow-up, 7% did not consult with a GP or practice nurse in
that period.
4.2. Comparison with existing evidence
With around 220,000 presentations of self-harm occurring
annually (Hawton et al., 2007), much of the research evidence for
self-harm in the UK and other developed countries has been
generated through studies conducted using hospital emergency
department and admissions data. Some evidence, does, however,
exist for patterns of consultation in primary care following self-
harm. One study found that most people consult with their GP
M.J. Carr et al. / Journal of Affective Disorders 197 (2016) 182–188 187soon after an episode, providing an opportunity to intervene and
prevent further episodes (Gunnell et al., 2002). We found the
overall rate of psychiatric referral to specialist mental health ser-
vices in the year following self-harm to be around just 15% for all
patients combined, which is lower than the 25% cited in relation to
hospital-based presentations (Kapur et al., 2006). Given the com-
plex health needs of this patient group, a higher referral rate by
GPs might be expected. Because of the lack of relevant research we
do not know what the optimal referral rate ought to be in this
population and setting, but the apparently low rate is certainly a
concern that merits further investigation. We have previously re-
ported from the CPRD that patients registered at practices in more
deprived localities have a higher incidence and annual presenta-
tion of self-harm (Carr et al., 2016). Thus, the decreasing referral
rate with heightened levels of socioeconomic deprivation that we
report here provides a clear illustration of Tudor Hart's ‘Inverse
Care Law’ (Tudor Hart, 1971), whereby the provision of services is
inversely associated with the level of needs in the population
(Chew-Graham et al., 2002; Mercer and Watt, 2007).
Many previous studies have documented the severe and com-
plex needs of people who have harmed themselves. This body of
evidence indicates why these individuals require optimal clinical
management in primary care. People who have self-harmed have a
very high prevalence of mental illness, particularly depression and
anxiety disorders in adults and attention deﬁcit hyperactivity
disorder (ADHD) and conduct disorder in adolescents (Hawton
et al., 2013). They commonly have comorbid substance misuse and
psychological distress (Moller et al., 2013), and they are also more
likely to perpetrate violence and be victims of it (Vaughn et al.,
2015). They are particularly prone to dying prematurely, speciﬁ-
cally by suicide or accidental poisoning (Cooper et al., 2007; Ber-
gen et al., 2012; Finkelstein et al., 2015a, 2015b) and from alcohol-
related causes (Bergen et al., 2014). In a cohort study conducted in
three English cities, mean potential Years of Life Lost (YLL) for all-
cause mortality were 31 4 years in males and 30 7 years in fe-
males (Bergen et al., 2012). As well as the apparent under-treat-
ment of these patients, the prescribing of psychotropic medication
without a psychiatric diagnosis is also potentially problematic,
because it represents a departure from evidence-based clinical
practice.
Careful prescribing is required for vulnerable primary care pa-
tients at elevated risk of self-poisoning (Hawton and Blackstock,
1976, 1977) and in particular those individuals who have already
harmed themselves. Monitoring patients in the early stages of
treatment is therefore essential, as is balancing the risks of suicide
and self-harm versus the efﬁcacy of medications in treating the
underlying mental illness (Gunnell et al., 2005). Many previous
studies have reported on the potentially harmful effects of speciﬁc
psychotropic medication classes. A comprehensive systematic re-
view on the topic highlighted tricyclic antidepressants and certain
types of selective serotonin reuptake inhibitor (SSRI) anti-
depressants as having heightened fatal toxicity risk in overdose
(Flanagan, 2008). Other research has conﬁrmed the toxicity of
tricyclics (Hawton et al., 2010) and have identiﬁed potential risks
in overdose associated with certain SSRIs (Gunnell et al., 2005),
most notably Citalopram (Hawton et al., 2010; Barbui and Patten,
2014).
One investigation reported aggregated Primary Care Trust
(PCT)-level antidepressant prescribing data in years 2004–2006
for three English cities, and patient-level data for emergency de-
partment self-poisoning cases at hospitals in these cities during
2000–2006 (Bergen et al., 2010). The authors described marked
inter-PCT variability in antidepressant prescribing patterns and
self-poisoning proﬁles with these drugs, and highlighted a speciﬁc
concern regarding the continued prescribing of toxic tricyclics in
this population. NICE clinical guideline 133 (CG133,recommendation 1.5.2; page 25) states: “When prescribing drugs
for associated mental health conditions to people who self-harm,
take into account the toxicity of the prescribed drugs in overdose.
For example, when considering antidepressants, selective ser-
otonin reuptake inhibitors (SSRIs) may be preferred because they
are less toxic than other classes of antidepressants. In particular,
do not use tricyclic antidepressants, such as dosulepin, because
they are more toxic.” On the NICE CG133 website, recommenda-
tion 1.5.2 is ﬂagged separately as being one of only three ‘Do not
do’ recommendations from that guideline (https://www.nice.org.
uk/guidance/cg133/resources/do-not-do). Although it was pub-
lished in November 2011, we found no evidence of a marked de-
cline in tricyclic prescribing for cohort members whose index self-
harm episodes occurred during 2012 and were followed up into
2013. Of course this is a relatively short post-intervention time
period, and it is feasible that prescription levels may have fallen
subsequently. Nonetheless, we did observe a sharp fall during
2012/2013 in the percentage of patients who were prescribed Ci-
talopram. This followed a Medicines and Healthcare products
Regulatory Agency (MHRA) safety alert issued in December 2011
that focussed on cardiovascular risks (https://www.gov.uk/drug-
safety-update/citalopram-and-escitalopram-qt-interval-
prolongation).
Almost four ﬁfths of patients who were prescribed a tricyclic
antidepressant during follow-up after their index self-harm epi-
sode had been prescribed an SSRI or some other antidepressant
drug agent previously. This indicates that tricyclics are generally
not being selected as ﬁrst-line treatment. Second-line use may
seem a more clinically justiﬁable option as the self-harm event
itself might suggest that the patient is not responding adequately
well to earlier treatment with alternative antidepressant medica-
tions. That other antidepressant drugs have usually been tried
previously adds useful insight into the challenges of clinical con-
sultation in primary care, although twenty two percent of these
patients appear to have been prescribed tricyclics in preference to
alternative antidepressant agents.
4.3. Strengths and limitations
Approximately 6.9% of the UK population is registered at
practices reporting data to the CPRD, which is broadly re-
presentative of the whole population nationally in terms of age,
gender and ethnicity (Herrett et al., 2015). From this resource we
extracted a large cohort to investigate a relatively rare phenom-
enon with abundant statistical power to examine subsequent
primary care management proﬁles. Observational studies con-
ducted in the CPRD rely on the standard of data inputted by GPs
and other practice staff members. Data quality is, however, care-
fully monitored, and we restricted our analysis to those practices
that were deemed to be up-to-standard for research purposes as
deﬁned by CPRD. The dataset conferred a number of speciﬁc ad-
vantages, including: (i) Diagnostic coding of a high standard (Khan
et al., 2010); (ii) Mandatory recording of referrals to mental health
services; and (iii) Recording of all medication prescribed in pri-
mary care. Our study did have some speciﬁc limitations. Firstly, we
had no information on the uptake of referrals, and we could not
determine whether a patient was already under the care of psy-
chiatric services or, indeed, the date of commencement of such
care. Secondly, psychological therapies and other non-medicinal
treatments were not systematically recorded in the dataset. Fi-
nally, we assigned deprivation scores at practice level as proxies
for patient-level measures.
5. Conclusions
Rates of referral to mental health services are relatively low
M.J. Carr et al. / Journal of Affective Disorders 197 (2016) 182–188188among these patients, and a stark health inequality is evident in
relation to a lower likelihood of being referred among patients
registered at practices located in more deprived areas. A greater
level of adherence to the 2011 NICE CG133 ‘Do not do’ re-
commendation against tricyclic antidepressant prescribing is also
indicated. However, our ﬁndings also indicate that sizeable pro-
portions of primary care patients move to another practice, or fail
to consult with a GP or nurse, within a year of harming them-
selves. This represents a major challenge for general practices in
monitoring these patients and in providing high quality care.
Guidelines for GPs on managing patients with history of self-harm
are currently limited, and further research is needed to determine
how risks might be lowered through improved primary care
clinical intervention.Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.jad.2016.03.013.References
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